Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial

被引：0
|
作者：
Jianhong Zhu
Wenxia Zhao
Dan Liang
Guocheng Li
Kaifeng Qiu
Junyan Wu
Jianfang Li
机构：
[1] Sun Yat-Sen Memorial Hospital,Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation
[2] Sun Yat-sen University,Department of Pharmacy
[3] Sun-Yat-Sen Memorial Hospital,undefined
[4] Sun Yat-sen University,undefined
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Anti-EGFR MAbs; Fatigue; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：389 / 399
页数：10
相关论文
共 50 条
  • [31] BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis
    Mao, Chen
    Liao, Ru-Yan
    Qiu, Li-Xin
    Wang, Xi-Wen
    Ding, Hong
    Chen, Qing
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (04) : 2219 - 2223
  • [32] BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis
    Chen Mao
    Ru-Yan Liao
    Li-Xin Qiu
    Xi-Wen Wang
    Hong Ding
    Qing Chen
    Molecular Biology Reports, 2011, 38 : 2219 - 2223
  • [33] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment:a meta-analysis
    Wei-Dong Shen
    Hong-Lin Chen
    Peng-Fei Liu
    Chinese Journal of Cancer Research, 2014, 26 (01) : 59 - 71
  • [34] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis
    Shen, Wei-Dong
    Chen, Hong-Lin
    Liu, Peng-Fei
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (01) : 59 - 71
  • [35] Risk of anti-EGFR monoclonal antibody-related skin rash: an up-to-date meta-analysis of 25 randomized controlled trials
    Qi, Wei-Xiang
    Sun, Yuan-Jue
    Shen, Zan
    Yao, Yang
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (06) : 359 - 368
  • [36] Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
    Vale, Claire L.
    Tierney, Jayne F.
    Fisher, David
    Adams, Richard A.
    Kaplan, Richard
    Maughan, Timothy S.
    Parmar, Mahesh K. B.
    Meade, Angela M.
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 618 - 625
  • [37] Efficacy and Safety of Anti-EGFR Therapy Rechallenge in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
    de Moraes, Francisco Cezar Aquino
    Rodrigues, Anna Luiza Soares de Oliveira
    Priantti, Jonathan N.
    Limachi-Choque, Jhonny
    Burbano, Rommel Mario Rodriguez
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [38] Exploring the risk of infection events in patients with asthma receiving anti-IL-5 monoclonal antibodies: A rapid systematic review and a meta-analysis
    Giossi, Riccardo
    Pani, Arianna
    Schroeder, Jan
    Scaglione, Francesco
    HELIYON, 2024, 10 (01)
  • [39] A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer
    Adelstein, Barbara-Ann
    Dobbins, Timothy A.
    Harris, Carole A.
    Marschner, Ian C.
    Ward, Robyn L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (09) : 1343 - 1354
  • [40] Anti-VEGF and anti-EGFR monoclonal antibodies (Mabs) in the first-line therapy for metastatic colorectal cancer: A meta-analysis
    Zhou, Z.
    Walsh, W. V.
    Bathini, V. G.
    Piperdi, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345